Rationale for dendritic cell-based vaccines for acute myeloid leukemia.
Biragyn
Arya
A
Laboratory of Immunology, National Institute on Aging, Baltimore, MD, USA. biragyna@nih.gov
D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000276:immunology*; D009363:Neoplasm Proteins / Q000276:immunology / Q000302:isolation & purification; D010446:Peptide Fragments / Q000276:immunology / Q000302:isolation & purification; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology
D009363:Neoplasm Proteins; D010446:Peptide Fragments